1. ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data. (28th January 2022) Authors: Moskovitz, Mor; Dudnik, Elizabeth; Shamai, Sivan; Rotenberg, Yakir; Popovich-Hadari, Noa; Wollner, Mira; Zer, Alona; Gottfried, Maya; Mishaeli, Moshe; Rosenberg, Shoshana Keren; Onn, Amir; Merimsky, Ofer; Urban, Damien; Peled, Nir; Maimon, Natalie; Bar, Jair Journal: Oncologist Issue: Volume 27:Number 1(2022) Page Start: e76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Alternative nivolumab duration and scheduling in advanced nonsmall cell lung cancer: A real‐world evidence. Issue 5 (16th September 2020) Authors: Dudnik, Elizabeth; Moskovitz, Mor; Agbarya, Abed; Gottfried, Teodor; Shochat, Tzippy; Urban, Damien; Zer, Alona; Rotem, Ofer; Moore, Assaf; Yust, Shlomit; Peled, Nir; Wollner, Mira; Bar, Jair Journal: International journal of cancer Issue: Volume 148:Issue 5(2021) Page Start: 1183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies. (22nd January 2019) Authors: Taha, Tarek; Meiri, David; Talhamy, Samira; Wollner, Mira; Peer, Avivit; Bar‐Sela, Gil Journal: Oncologist Issue: Volume 24:Number 4(2019) Page Start: 549 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life data. (December 2018) Authors: Dudnik, Elizabeth; Moskovitz, Mor; Daher, Sameh; Shamai, Sivan; Hanovich, Ekaterina; Grubstein, Ahuva; Shochat, Tzippy; Wollner, Mira; Bar, Jair; Merimsky, Ofer; Zer, Alona; Goldstein, Daniel A.; Hammerman, Ariel; Cyjon, Arnold; Shechtman, Yelena; Abu-Amna, Mahmood; Flex, Dov; Roisman, Laila C.; ... Journal: Lung cancer Issue: Volume 126(2018) Page Start: 217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Immune-related Neutropenia Following Treatment With Immune Checkpoint Inhibitors. Issue 2 (February 2020) Authors: Finkel, Inbar; Sternschuss, Michal; Wollner, Mira; Shamai, Sivan; Peled, Nir; Turgeman, Ilit; Shochat, Tzippy; Dudnik, Elizabeth Journal: Journal of immunotherapy Issue: Volume 43:Issue 2(2020:Feb./Mar.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lower lung cancer rates in Jewish smokers in Israel and the USA. Issue 9 (18th May 2015) Authors: Rennert, Gad; Kremer, Ran; Rennert, Hedy S.; Wollner, Mira; Agbarya, Abed; Pinchev, Mila; Lejbkowicz, Flavio; Spitz, Margaret R.; Muscat, Joshua E. Journal: International journal of cancer Issue: Volume 137:Issue 9(2015:Nov. 01) Page Start: 2155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Oxaliplatin-Induced Pulmonary Toxicity in Gastrointestinal Malignancies: Two Case Reports and Review of the Literature. (10th May 2015) Authors: Moskovitz, Mor; Wollner, Mira; Haim, Nissim Other Names: Lindquist David Academic Editor. Journal: Case reports in oncological medicine Issue: Volume 2015(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data. (1st January 2021) Authors: Dudnik, Elizabeth; Moskovitz, Mor; Rottenberg, Yakir; Lobachov, Anastasiya; Mandelboim, Rinat; Shochat, Tzippy; Urban, Damien; Wollner, Mira; Nechushtan, Hovav; Rotem, Ofer; Zer, Alona; Daher, Sameh; Bar, Jair Journal: Oncoimmunology Issue: Volume 10:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung. Issue 2 (17th February 2021) Authors: Dudnik, Elizabeth; Kareff, Samuel; Moskovitz, Mor; Kim, Chul; Liu, Stephen V; Lobachov, Anastasiya; Gottfried, Teodor; Urban, Damien; Zer, Alona; Rotem, Ofer; Onn, Amir; Wollner, Mira; Bar, Jair Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Severe complicated neutropenia in two patients with metastatic non-small-cell lung cancer treated with nivolumab. Issue 7 (August 2017) Authors: Turgeman, Ilit; Wollner, Mira; Hassoun, Gamal; Bonstein, Lilach; Bar-Sela, Gil Journal: Anti-cancer drugs Issue: Volume 28:Issue 7(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗